ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurologic Disorders Therapeutics Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30S13903
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Neurologic Disorders Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Neurologic Disorders Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-30S13903
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biogen
F Hoffmann La Roche Ltd
Johnson & Johnson Services Inc.
Novartis
Pfizer Inc

Neurologic Disorders Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neurologic Disorders Therapeutics Market

Neurologic Disorders Therapeutics Market

A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
Market Analysis and Insights: Global Neurologic Disorders Therapeutics Market
The global Neurologic Disorders Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Neurologic Disorders Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurologic Disorders Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Neurologic Disorders Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurologic Disorders Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neurologic Disorders Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neurologic Disorders Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Neurologic Disorders Therapeutics Market Report

Report Metric Details
Report Name Neurologic Disorders Therapeutics Market
CAGR 5%
Segment by Type
  • Central Nervous System (CNS)
  • Peripheral Nervous System (PNS)
Segment by Application
  • Paralysis
  • Muscle Weakness
  • Poor Coordination
  • Loss of Sensation
  • Seizures
  • Confusion
  • Pain and Altered Levels of Consciousness
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Neurologic Disorders Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurologic Disorders Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurologic Disorders Therapeutics revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Neurologic Disorders Therapeutics Market report?

Ans: The main players in the Neurologic Disorders Therapeutics Market are Biogen Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc.

What are the Application segmentation covered in the Neurologic Disorders Therapeutics Market report?

Ans: The Applications covered in the Neurologic Disorders Therapeutics Market report are Paralysis, Muscle Weakness, Poor Coordination, Loss of Sensation, Seizures, Confusion, Pain and Altered Levels of Consciousness

What are the Type segmentation covered in the Neurologic Disorders Therapeutics Market report?

Ans: The Types covered in the Neurologic Disorders Therapeutics Market report are Central Nervous System (CNS), Peripheral Nervous System (PNS)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Central Nervous System (CNS)
1.2.3 Peripheral Nervous System (PNS)
1.3 Market by Application
1.3.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Paralysis
1.3.3 Muscle Weakness
1.3.4 Poor Coordination
1.3.5 Loss of Sensation
1.3.6 Seizures
1.3.7 Confusion
1.3.8 Pain and Altered Levels of Consciousness
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurologic Disorders Therapeutics Market Perspective (2019-2030)
2.2 Global Neurologic Disorders Therapeutics Growth Trends by Region
2.2.1 Neurologic Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurologic Disorders Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Neurologic Disorders Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Neurologic Disorders Therapeutics Market Dynamics
2.3.1 Neurologic Disorders Therapeutics Industry Trends
2.3.2 Neurologic Disorders Therapeutics Market Drivers
2.3.3 Neurologic Disorders Therapeutics Market Challenges
2.3.4 Neurologic Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurologic Disorders Therapeutics by Players
3.1.1 Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurologic Disorders Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Neurologic Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorders Therapeutics Revenue in 2023
3.5 Global Key Players of Neurologic Disorders Therapeutics Head office and Area Served
3.6 Global Key Players of Neurologic Disorders Therapeutics, Product and Application
3.7 Global Key Players of Neurologic Disorders Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurologic Disorders Therapeutics Breakdown Data by Type
4.1 Global Neurologic Disorders Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2025-2030)
5 Neurologic Disorders Therapeutics Breakdown Data by Application
5.1 Global Neurologic Disorders Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurologic Disorders Therapeutics Market Size (2019-2030)
6.2 North America Neurologic Disorders Therapeutics Market Size by Type
6.2.1 North America Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Neurologic Disorders Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
6.3 North America Neurologic Disorders Therapeutics Market Size by Application
6.3.1 North America Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Neurologic Disorders Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
6.4 North America Neurologic Disorders Therapeutics Market Size by Country
6.4.1 North America Neurologic Disorders Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Neurologic Disorders Therapeutics Market Size (2019-2030)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type
7.2.1 Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application
7.3.1 Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Neurologic Disorders Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
7.4 Europe Neurologic Disorders Therapeutics Market Size by Country
7.4.1 Europe Neurologic Disorders Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurologic Disorders Therapeutics Market Size (2019-2030)
8.2 China Neurologic Disorders Therapeutics Market Size by Type
8.2.1 China Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
8.2.2 China Neurologic Disorders Therapeutics Market Size by Type (2025-2030)
8.2.3 China Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
8.3 China Neurologic Disorders Therapeutics Market Size by Application
8.3.1 China Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
8.3.2 China Neurologic Disorders Therapeutics Market Size by Application (2025-2030)
8.3.3 China Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Neurologic Disorders Therapeutics Market Size (2019-2030)
9.2 Asia Neurologic Disorders Therapeutics Market Size by Type
9.2.1 Asia Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Neurologic Disorders Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
9.3 Asia Neurologic Disorders Therapeutics Market Size by Application
9.3.1 Asia Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Neurologic Disorders Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
9.4 Asia Neurologic Disorders Therapeutics Market Size by Region
9.4.1 Asia Neurologic Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Neurologic Disorders Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Neurologic Disorders Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Details
11.1.2 Biogen Inc. Business Overview
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Introduction
11.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.1.5 Biogen Inc. Recent Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Details
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.3.5 Johnson & Johnson Services Inc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Neurologic Disorders Therapeutics Introduction
11.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024)
11.5.5 Pfizer Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Biogen
F Hoffmann La Roche Ltd
Johnson & Johnson Services Inc.
Novartis
Pfizer Inc
List of Tables
    Table 1. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Central Nervous System (CNS)
    Table 3. Key Players of Peripheral Nervous System (PNS)
    Table 4. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Neurologic Disorders Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Neurologic Disorders Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Neurologic Disorders Therapeutics Market Share by Region (2025-2030)
    Table 10. Neurologic Disorders Therapeutics Market Trends
    Table 11. Neurologic Disorders Therapeutics Market Drivers
    Table 12. Neurologic Disorders Therapeutics Market Challenges
    Table 13. Neurologic Disorders Therapeutics Market Restraints
    Table 14. Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Neurologic Disorders Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Neurologic Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorders Therapeutics as of 2023)
    Table 17. Global Neurologic Disorders Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Neurologic Disorders Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Neurologic Disorders Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Neurologic Disorders Therapeutics, Product and Application
    Table 21. Global Key Players of Neurologic Disorders Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Neurologic Disorders Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Neurologic Disorders Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Neurologic Disorders Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Neurologic Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Neurologic Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Neurologic Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Neurologic Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Neurologic Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Neurologic Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Neurologic Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Neurologic Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Neurologic Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Neurologic Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Neurologic Disorders Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Neurologic Disorders Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Biogen Inc. Company Details
    Table 64. Biogen Inc. Business Overview
    Table 65. Biogen Inc. Neurologic Disorders Therapeutics Product
    Table 66. Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Biogen Inc. Recent Developments
    Table 68. F. Hoffmann-La Roche Ltd. Company Details
    Table 69. F. Hoffmann-La Roche Ltd. Business Overview
    Table 70. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product
    Table 71. F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 73. Johnson & Johnson Services Inc. Company Details
    Table 74. Johnson & Johnson Services Inc. Business Overview
    Table 75. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product
    Table 76. Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Johnson & Johnson Services Inc. Recent Developments
    Table 78. Novartis AG Company Details
    Table 79. Novartis AG Business Overview
    Table 80. Novartis AG Neurologic Disorders Therapeutics Product
    Table 81. Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Novartis AG Recent Developments
    Table 83. Pfizer Inc. Company Details
    Table 84. Pfizer Inc. Business Overview
    Table 85. Pfizer Inc. Neurologic Disorders Therapeutics Product
    Table 86. Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Pfizer Inc. Recent Developments
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Neurologic Disorders Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Central Nervous System (CNS) Features
    Figure 4. Peripheral Nervous System (PNS) Features
    Figure 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Neurologic Disorders Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. Paralysis Case Studies
    Figure 8. Muscle Weakness Case Studies
    Figure 9. Poor Coordination Case Studies
    Figure 10. Loss of Sensation Case Studies
    Figure 11. Seizures Case Studies
    Figure 12. Confusion Case Studies
    Figure 13. Pain and Altered Levels of Consciousness Case Studies
    Figure 14. Neurologic Disorders Therapeutics Report Years Considered
    Figure 15. Global Neurologic Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Neurologic Disorders Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Neurologic Disorders Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global Neurologic Disorders Therapeutics Market Share by Players in 2023
    Figure 19. Global Top Neurologic Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurologic Disorders Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Neurologic Disorders Therapeutics Revenue in 2023
    Figure 21. North America Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 23. North America Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 24. North America Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 25. United States Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Neurologic Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 29. Europe Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 30. Europe Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 31. Germany Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Neurologic Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 39. China Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Neurologic Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 42. Asia Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 43. Asia Neurologic Disorders Therapeutics Market Share by Region (2019-2030)
    Figure 44. Japan Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Neurologic Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 54. Brazil Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Neurologic Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Biogen Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 62. Johnson & Johnson Services Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 63. Novartis AG Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 64. Pfizer Inc. Revenue Growth Rate in Neurologic Disorders Therapeutics Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Lennox-Gastaut Syndrome Treatment Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-20K5940
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Implantable Neurostimulation System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1Y15335
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Implantable Nerve Stimulation Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37G12498
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Neurologic Disorders Therapeutics Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-30S13903
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions